Stephanie W. Lo,Kate Mellor,Robert Cohen,Alba Redin Alonso,Sophie Belman,Narender Kumar,Paulina A. Hawkins,Rebecca A. Gladstone,Anne von Gottberg,Balaji Veeraraghavan,K. L. Ravikumar,Rama Kandasamy,Sir Andrew J. Pollard,Samir K. Saha,Godfrey Bigogo,Martin Antonio,Brenda Kwambana-Adams,Shaper Mirza,Sadia Shakoor,Imran Nisar,Jennifer E. Cornick,Deborah Lehmann,Rebecca L. Ford,Betuel Sigauque,Paul Turner,Jennifer Moisi,Stephen K. Obaro,Ron Dagan,Idrissa Diawara,Anna Skoczynska,Hui Wang,Philip E. Carter,Keith P. Klugman,Gail Rodgers,Robert F. Breiman,Lesley McGee,Stephen D. Bentley,Carmen Munoz-Almagro,Emmanuelle Varon

Abstract:Background Serotype 24F is one of the emerging pneumococcal serotypes after the introduction of pneumococcal conjugate vaccine (PCV). We aimed to identify lineages driving the increase of serotype 24F in France and place these findings into a global context. Methods Whole-genome sequencing was performed on a collection of serotype 24F pneumococci from asymptomatic colonisation (n=229) and invasive disease (n=190) isolates among individuals younger than 18 years in France, from 2003 to 2018. To provide a global context, we included an additional collection of 24F isolates in the Global Pneumococcal Sequencing (GPS) project database for analysis. A Global Pneumococcal Sequence Cluster (GPSC) and a clonal complex (CC) were assigned to each genome. Phylogenetic, evolutionary, and spatiotemporal analysis were conducted using the same 24F collection and supplemented with a global collection of genomes belonging to the lineage of interest from the GPS project database (n=25 590). Findings Serotype 24F was identified in numerous countries mainly due to the clonal spread of three lineages: GPSC10 (CC230), GPSC16 (CC156), and GPSC206 (CC7701). GPSC10 was the only multidrug-resistant lineage. GPSC10 drove the increase in 24F in France and had high invasive disease potential. The international dataset of GPSC10 (n=888) revealed that this lineage expressed 16 other serotypes, with only six included in 13-valent PCV (PCV13). All serotype 24F isolates were clustered in a single clade within the GPSC10 phylogeny and long-range transmissions were detected from Europe to other continents. Spatiotemporal analysis showed GPSC10-24F took 3-5 years to spread across France and a rapid change of serotype composition from PCV13 serotype 19A to 24F during the introduction of PCV13 was observed in neighbouring country Spain. Interpretation Our work reveals that GPSC10 alone is a challenge for serotype-based vaccine strategy. More systematic investigation to identify lineages like GPSC10 will better inform and improve next-generation preventive strategies against pneumococcal diseases. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd.

A genome-based survey of invasive pneumococci in Norway over four decades reveals lineage-specific responses to vaccination

Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 8 in Denmark

Pneumococcal population genomics changes during the early time period of conjugate vaccine uptake in southern India

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children

Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader

Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States

Non-invasive Streptococcus pneumoniae infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023

The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi

High diversity within and low but significant genetic differentiation among geographic and temporal populations of the global Streptococcus pneumoniae

High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland

Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998-2022

Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine

Emergence of a Multidrug-Resistant and Virulent Streptococcus Pneumoniae Lineage Mediates Serotype Replacement after PCV13: an International Whole-Genome Sequencing Study.

Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 24F in Denmark

Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999–2021

Serotype distribution, antibiotic resistance, multilocus sequence typing, and virulence factors of invasive and non-invasive Streptococcus pneumoniae in Northeast China from 2000 to 2021

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe

Genomic characterization of Streptococcus pneumoniae isolates among pediatric patients in Addis Ababa, Ethiopia

The antimicrobial resistance profile of Streptococcus pneumoniae

Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska